CTLA4 and neoplasm: Following the ILP procedure, tumour‐bearing animals received an intraperitoneal injection of anti‐CTLA‐4 antibody, anti‐PD‐1 antibody or an isotype control, at day 8, 10 and 12 post‐implantation.